2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$37.03+$1.32 (+3.69%)
Price as of Nov 11, 2026 7:49 PM EST- $7.4BMarket Cap
- 56.01%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$37.03+$1.32 (+3.69%)
IMVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.71 | ||
Change | +$0.56 (+1.59%) | ||
Open | $35.15 | ||
High | $35.98 | ||
Low | $34.83 | ||
Previous Close | $35.15 | ||
Volume | 1,644,284 | ||
30-Day Average Volume | 1,526,318 | ||
1-Week Change | 22.97% | ||
1-Month Change | 17.20% | ||
1-Year Change | 56.01% | ||
3-Year Change | 9.44% | ||
5-Year Change | 310.93% | ||
Fundamentals | |||
Shares Outstanding | 206.6M | ||
Total Assets | $761.0M | ||
Market Cap | $7.4B | ||
Enterprise Value | $6.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$97.2M | ||
Free Cash Flow | -$83.2M | ||
EBIT | -$97.2M | ||
EBITDA | -$97.2M | ||
Net Working Capital | $656.0M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -68 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 11 | ||
P/E | -76 | ||
PEG | -2 | ||
Price/Free Cash Flow | -89 | ||
Price/Operating Cash Flow | -89 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue